Literature DB >> 8500519

Phenotypically diverse mouse thymic stromal cell lines which induce proliferation and differentiation of hematopoietic cells.

S J Faas1, J L Rothstein, B L Kreider, G Rovera, B B Knowles.   

Abstract

The heterogeneity of the thymic stroma has made careful characterization of particular thymic stromal cell types difficult. To this end, we have derived a panel of cloned thymic stromal cell lines from simian virus 40 T antigen (SV40-T antigen) transgenic mice. Based on their analysis with monoclonal antibodies that distinguish among subsets of thymic stroma cells, and on the morphology and ultrastructural features of the different clones, we suggest that our panel includes representatives of the thymic subcapsular cortex or thymic nurse cells (427.1), the deep cortex or cortical reticular cells (1308.1) and the medulla including medullary interdigitating (IDC)-like cells (6.1.1) and medullary epithelial cells (6.1.7). A fifth cell type of undesignated but apparent medullary origin (6.1.11) was also isolated. All of the cell lines constitutively express the SV40 T antigen transgene and the class I antigens of the major histocompatibility complex (MHC), and they can be induced to express MHC class II antigens upon stimulation with recombinant interferon-gamma (IFN-gamma). These cell lines elaborate a factor(s) that induces the proliferation of cells from the fetal liver and bone marrow, but not from the neonatal thymus. A factor(s) elaborated by the 1308.1 cell line also induces the proliferation of fetal thymocytes in the absence of mitogens, phorbol esters or calcium ionophore which is augmented with the addition of recombinant interleukin-2 (IL-2). Analysis by reverse transcription polymerase chain reaction with primers for some mouse cytokines reveals that each of these cell lines contain granulocyte-macrophage colony-stimulating factor (GM-CSF) transcripts and that 1308.1, 6.1.1 and 6.1.7 produce IL-6 mRNA. Cell lines 1308.1 and 6.1.1 also produce IL-7; 6.1.1 produces IL-1 beta and tumor necrosis factor (TNF)-alpha while the 427.1 cell line produces IL-5 and IFN-gamma mRNA. None of the cell lines tested express the IL-2 receptor, IL-2, IL-3, IL-4, TNF-beta or macrophage inflammatory proteins mRNA. Conditioned medium (CM) from 1308.1 and 6.1.11 induced differentiation of cells purified from the mouse fetal liver into granulocytes; 1308.1 CM also induced differentiation of the mouse hematopoietic stem cell line 32DCl3(G) suggesting that the CM contains granulocyte (G)-CSF activity. Each cell line produces GM-CSF but the greatest activity is associated with 1308.1 and 6.1.11 CM. The availability of these well-characterized, functional, cloned thymic stromal cells will allow a more detailed analysis of the role of each cell type in both myeloid and T cell development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500519     DOI: 10.1002/eji.1830230602

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  IL-7 production in murine lymphatic endothelial cells and induction in the setting of peripheral lymphopenia.

Authors:  Corey N Miller; Dennis J Hartigan-O'Connor; Myeong Sup Lee; Grace Laidlaw; Ivo P Cornelissen; Mehrdad Matloubian; Shaun R Coughlin; Donald M McDonald; Joseph M McCune
Journal:  Int Immunol       Date:  2013-05-08       Impact factor: 4.823

2.  Identification and characterization of thymus LIM protein: targeted disruption reduces thymus cellularity.

Authors:  J Kirchner; K A Forbush; M J Bevan
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells.

Authors:  Simona W Rossi; Lukas T Jeker; Tomoo Ueno; Sachiyo Kuse; Marcel P Keller; Saulius Zuklys; Andrei V Gudkov; Yousuke Takahama; Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

4.  Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri.

Authors:  Stephanie P Jehl; Amy M Doling; Kara S Giddings; Armelle Phalipon; Philippe J Sansonetti; Marcia B Goldberg; Michael N Starnbach
Journal:  Infect Immun       Date:  2011-02-28       Impact factor: 3.441

5.  Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas.

Authors:  I Marton; S E Johnson; I Damjanov; K S Currier; J P Sundberg; B B Knowles
Journal:  Transgenic Res       Date:  2000-04       Impact factor: 2.788

6.  Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.

Authors:  X Ye; J McCarrick; L Jewett; B B Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  The innate immune system recognizes and regulates major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells.

Authors:  Bent Rubin; Joëlle Riond; Laetitia Courtiade; Nicolas Roullet; Jean-Edouard Gairin
Journal:  Cancer Immun       Date:  2008-09-11

8.  RANKL stimulates proliferation, adhesion and IL-7 expression of thymic epithelial cells.

Authors:  Hee Woo Lee; Hye Kyung Park; Yong Jin Na; Chi Dae Kim; Jung Hoon Lee; Bong Seon Kim; Jae Bong Kim; Choong Won Lee; Jeon Ok Moon; Sik Yoon
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

9.  Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration.

Authors:  Young-Mi Kim; Hye Kyung Kim; Hyo Jin Kim; Hee-Woo Lee; Seong-A Ju; Beom K Choi; Byoung S Kwon; Bong-Seon Kim; Jae-Bong Kim; Young-Tak Lim; Sik Yoon
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

10.  Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes.

Authors:  Anne Sarén; Steve Pascolo; Stefan Stevanovic; Tilman Dumrese; Mirja Puolakkainen; Matti Sarvas; Hans-Georg Rammensee; Jenni M Vuola
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.